Stacker; Steven

Patent Applications and Registrations

Patent applications and USPTO patent grants for Stacker; Steven.The latest application filed is for "antibodies against human ryk and uses therefor".

Company Profile

0.8.13

Stacker; Steven - North Balwyn AU
Stacker; Steven - Melbourne AU
Stacker; Steven - New York NY
Stacker; Steven - Victoria AU
Stacker; Steven - Parkville AU
Stacker; Steven - North Fitzroy AU
Stacker, Steven - Parville AU

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Antibodies against human RYK and uses therefor Grant 9,862,776 - Macheda , et al. January 9, 2	2018-01-09
Antibodies Against Human Ryk And Uses Therefor App 20160053022 - Macheda; Maria Luisa ; et al.	2016-02-25
Methods of using VEGF-D polypeptides Grant 7,928,061 - Achen , et al. April 19, 2	2011-04-19
Mammalian cells that express VEGF-D polypeptides Grant 7,871,798 - Achen , et al. January 18, 2	2011-01-18
Methods And Compositions For Activating Or Inhibiting Vegf-d And Vegf-c App 20090169551 - McColl; Bradley ; et al.	2009-07-02
Methods for treating neoplastic disease characterized by vascular endothelial growth factor D expression, for screening for neoplastic disease or metastatic risk, and for maintaining vascularization of tissue Grant 7,534,572 - Achen , et al. May 19, 2	2009-05-19
Methods and compositions for activating VEGF-D and VEGF-C Grant 7,479,270 - McColl , et al. January 20, 2	2009-01-20
Methods for Inhibiting Angiogenesis and/or Lymphangiogenesis App 20070224194 - McColl; Bradley ; et al.	2007-09-27
Protease-resistant forms of VEGF-D, method of making and method of use App 20070212390 - Paavonen; Karri ; et al.	2007-09-13
Vascular endothelial growth factor D (VEGF-D) antibodies and vectors, and methods of use Grant 7,122,654 - Achen , et al. October 17, 2	2006-10-17
VEGF-D/VEGF-C/VEGF peptidomimetic inhibitor Grant 7,045,133 - Achen , et al. May 16, 2	2006-05-16
Methods and compositions for activating or inhibiting vegf-d and vegf-c App 20050282228 - Mccoll, Bradley ; et al.	2005-12-22
Multivalent antibody materials and methods for VEGF/PDGF family of growth factors App 20050282233 - Eriksson, Ulf ; et al.	2005-12-22
Methods for inhibiting angiogenesis and or lymphangiogenesis App 20050272664 - McColl, Bradley ; et al.	2005-12-08
Methods for treating neoplastic disease characterized by vascular endothelial growth factor D expression, for screening for neoplastic disease or metastatic risk, and for maintaining vascularization of tissue App 20050202015 - Achen, Marc ; et al.	2005-09-15
Method of diagnosising abnormalities by screening for tyrosine kinase like molecules or their signalling mediators App 20040115660 - Stacker, Steven ; et al.	2004-06-17
Method for activating only the vascular endothelial growth factor receptor-3 and uses thereof Grant 6,689,352 - Achen , et al. February 10, 2	2004-02-10
Method for activating only the vascular endothelial growth factor receptor-3 and uses thereof App 20030166523 - Achen, Marc ; et al.	2003-09-04
Methods for treating neoplastic disease characterized by vascular endothelial growth factor D expression, for screening for neoplastic disease or metastatic risk, and for maintaining vascularization of tissue App 20020102260 - Achen, Marc ; et al.	2002-08-01
VEGF-D/VEGF-C/VEGF peptidomimetic inhibitor App 20020065218 - Achen, Marc G. ; et al.	2002-05-30
Methods for treating various cancers expressing vascular endothelial growth factor D, for screening for a neoplastic disease and for maintaining vascularization of tissue App 20010038842 - Achen, Marc ; et al.	2001-11-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.